SCOPUS 정보 검색 플랫폼

Volumn 46, Issue 6, 2002, Pages 1443-1450

Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two-year radiographic and clinical outcomes

(14) Genovese, Mark C a,n Bathon, Joan M b Martin, Richard W c Fleischmann, Roy M d Tesser, John R e Schiff, Michael H f Keystone, Edward C g Wasko, Mary Chester h Moreland, Larry W i Weaver, Arthur L j Markenson, Joseph k Cannon, Grant W l Spencer Green, George m Finck, Barbara K m

a STANFORD UNIVERSITY (United States)

b JOHNS HOPKINS UNIVERSITY (United States)

c MICHIGAN STATE UNIVERSITY (United States)

d RADIANT RESEARCH (United States)

e Phoenix Center for Clinical Research (United States)

f Denver Arthritis Clinic PC (United States)

g UNIVERSITY OF TORONTO (Canada)

h UNIVERSITY OF PITTSBURGH MEDICAL CENTER (United States)

i UNIVERSITY OF ALABAMA AT BIRMINGHAM (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ETANERCEPT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ADULT; AGED; ALOPECIA; ARTHRITIS; ARTICLE; BONE RADIOGRAPHY; CLINICAL TRIAL; DISABILITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; INJECTION SITE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISABILITY EVALUATION; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; METHOTREXATE; MIDDLE AGED; PATIENT DROPOUTS; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME;

EID: 0036274944 PISSN: 00043591 EISSN: None Source Type: Journal
DOI: 10.1002/art.10308 Document Type: Article

Times cited : (726)

References (21)

1
- 0034735827
- A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
- (2000) N Engl J Med , vol.343 , pp. 1586-1593
- Bathon, J.M.¹ Martin, R.W.² Fleischmann, R.M.³ Tesser, J.R.⁴ Schiff, M.H.⁵ Keystone, E.C.⁶

2
- 0013511183
- Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
- (1997) N Engl J Med , vol.337 , pp. 141-147
- Moreland, L.W.¹ Baumgartner, S.W.² Schiff, M.H.³ Tindall, E.A.⁴ Fleischmann, R.M.⁵ Weaver, A.L.⁶

3
- 0033574147
- Etanercept therapy in rheumatoid arthritis: A randomized, controlled trial
- (1999) Ann Intern Med , vol.130 , pp. 478-486
- Moreland, L.¹ Schiff, M.H.² Baumgartner, S.W.³ Tindall, E.A.⁴ Fleischmann, R.M.⁵ Bulpitt, K.J.⁶

4
- 0033611472
- A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
- (1999) N Engl J Med , vol.340 , pp. 253-259
- Weinblatt, M.E.¹ Kremer, J.M.² Bankhurst, A.D.³ Bulpitt, K.J.⁴ Fleischmann, R.M.⁵ Fox, R.I.⁶

5
- 0034743750
- Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis
- (2001) J Rheumatol , vol.28 , pp. 1238-1244
- Moreland, L.W.¹ Cohen, S.B.² Baumgartner, S.W.³ Tindall, E.A.⁴ Bulpitt, K.J.⁵ Martin, R.W.⁶

6
- 0034673697
- Etanercept in children with polyarticular juvenile rheumatoid arthritis
- (2000) N Engl J Med , vol.342 , pp. 763-769
- Lovell, D.¹ Giannini, E.² Reiff, A.³ Cawkwell, G.⁴ Silverman, E.⁵ Nocton, J.⁶

7
- 0034101656
- Modeling therapeutic strategies in rheumatoid arthritis: Use of decision analysis and Markov models
- (2000) J Rheumatol , vol.27 , pp. 644-652
- Albert, D.A.¹ Aksentijevich, S.² Hurst, S.³ Fries, J.F.⁴ Wolfe, F.⁵

8
- 0029044362
- American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis
- (1995) Arthritis Rheum , vol.38 , pp. 727-735
- Felson, D.T.¹ Anderson, J.J.² Boers, M.³ Bombardier, C.⁴ Furst, D.⁵ Goldsmith, C.⁶

9
- 4243823091
- 100 Micron digitization resolution is optimal for x-rays for a large multicenter trial in rheumatoid arthritis (RA)
- (1997) Arthritis Rheum , vol.40
- Finck, B.K.¹ Weissman, B.N.W.² Rubenstein, J.D.³ Salonen, D.⁴ Einstein, S.G.⁵ Lange, M.⁶

10
- 0020188574
- The dimensions of health outcomes: The health assessment questionnaire, disability and pain scales
- (1982) J Rheumatol , vol.9 , pp. 789-793
- Fries, J.F.¹ Spitz, P.W.² Young, D.Y.³

11
- 0026567394
- Clinical trials in psychiatry: Should protocol deviation censor patient data?
- (1992) Neuropsychopharmacology , vol.6 , pp. 39-63
- Lavori, P.W.¹

12
- 0003471085
- Oakland: Holden-Day
- (1976) Nonparametrics: statistical methods based on ranks
- Lehmann, E.L.¹

13
- 0027412974
- Minimum important difference between patients with rheumatoid arthritis: The patient's perspective
- (1993) J Rheumatol , vol.20 , pp. 557-560
- Wells, G.A.¹ Tugwell, P.² Kraag, G.R.³ Baker, P.R.⁴ Groh, J.⁵ Redelmeier, D.A.⁶

14
- 0001133619
- Methotrexate-induced pulmonary disease during treatment of rheumatoid arthritis in large clinical trials
- (2000) Arthritis Rheum , vol.43
- Cannon, G.W.¹ Finck, B.K.²

15
- 0031014450
- Cancer statistics, 1997
- (1997) CA Cancer J Clin , vol.47 , pp. 5-27
- Parker, S.L.¹ Tong, T.² Bolden, S.³ Wingo, P.A.⁴

16
- 0033596065
- Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate
- (1999) Arch Intern Med , vol.159 , pp. 2542-2550
- Strand, V.¹ Cohen, S.² Schiff, M.³ Weaver, A.⁴ Fleischmann, R.⁵ Cannon, G.⁶

17
- 0034735842
- Infliximab and methotrexate in the treatment of rheumatoid arthritis
- (2000) N Engl J Med , vol.343 , pp. 1594-1602
- Lipsky, P.E.¹ Van der Heijde, D.M.² St Clair, E.W.³ Furst, D.E.⁴ Breedveld, F.C.⁵ Kalden, J.R.⁶

18
- 0033524159
- Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial
- (1999) Lancet , vol.354 , pp. 1932-1939
- Maini, R.¹ St Clair, E.W.² Breedveld, F.³ Furst, D.⁴ Kalden, J.⁵ Weisman, M.⁶

19
- 0034082253
- Factors predicting response to treatment in rheumatoid arthritis: The importance of disease duration
- (2000) Arthritis Rheum , vol.43 , pp. 22-29
- Anderson, J.J.¹ Wells, G.² Verhoeven, A.C.³ Felson, D.T.⁴

20
- 0034116168
- Factors influencing length of time taking methotrexate in rheumatoid arthritis
- (2000) J Rheumatol , vol.27 , pp. 1139-1147
- Ortendahl, M.¹ Schettler, J.D.² Fries, J.F.³

21
- 0028800090
- The epidemiology of drug treatment failure in rheumatoid arthritis
- (1995) Baillieres Clin Rheumatol , vol.9 , pp. 619-632
- Wolfe, F.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.